Best Pharma Stocks to Buy Right Now

The potential of stocks may depend on the relevant pharmaceutical development and the overall market value.



A quick search on Google and you’ll find plenty of options listed under ‘top pharma stocks’ that you can buy right now. Of course, some of them are more profitable than others. The potential of each stock depends on many aspects, including the relevant pharmaceutical development and the overall market value. Although several top pharmaceutical stocks are holding up well amid the Covid-19 crisis, including Pfizer stock, and have the potential to be stock market favorites for a long time.

These pharma stocks to buy or watch aren’t hard to find, as long as you’re keeping an eye on the stock market. Whether it’s a renowned name like J&J or a lesser-known name like Cerecor, the best pharma stocks share a few common things. Let’s find out…

Investing In Best Pharma Stocks

The best pharma stocks boast strong performance in the pharmaceutical sector. Many sell at a substantial premium, however a high valuation is guaranteed due to their growth prospects. Industry Leaders has come up with a brief list of the best pharmaceutical stocks you can buy right now, along with a list of pharma stocks that have the best potential to grow in the near future.

best top pharma stocks to buy

The best pharma penny stocks are there to offer you the best return on investment.

Pfizer Stock

Pfizer is the first on this list of best pharma stocks to buy because of many reasons. First of all, this company showed a prompt reaction when Covid-19 entered the world stage. They produced a vaccine that was approved as the medical response against the disease. 

Also, they manufactured many well-known drugs, like EpiPen, Dimetapp, and Neosporin. All these drugs are proven to be effective and the company ranks high on the list of the top pharma stocks to buy right now. 

Johnson & Johnson Stock

Johnson & Johnson is another example of a company where you can invest in the best value pharmaceutical stocks. The company produces the immunology drugs Tremfya and Stelara, as well as cancer drugs Erleada and Darzalex. 

J&J has also been developing a Covid-19 vaccine, but some manufacturing issues are affecting the overall distribution of the vaccine. The officials need to approve the vaccine and let the company present it to a larger public as an effective vaccine against the disease. 

AbbVie Stock

AbbVie is producing one of the most popular drugs called Humira. It is one of the most effective drugs for rheumatoid arthritis. The annual revenue from this drug exceeds the amount of $1 billion, which is quite impressive. 

At the same time, the company’s dividend has been rising for 49 years in a row, which makes the company one of the best value pharmaceutical stocks choices. 

The company is also developing promising drugs for many diseases, including Parkinson’s disease, migraines, and myelofibrosis. 

Bristol-Myers Squibb Stock

This New York-based drugmaker is offering solutions for medical conditions like cancer, blood disorders, psoriatic arthritis, and hepatitis B. A price target of one share is estimated to be $74, while there is a Massachusetts-based firm Berkshire Hathaway as a leading shareholder. It is projected the shareholder owns over 26 million shares that have a value of more than $1.75 billion.

This is quite impressive for the Bristol-Myers Squibb company and it adds value to each stock that is on the market right now. 

Eli Lilly and Company Stock

Eli Lilly and Company ranks high on the list of top pharma stocks to buy now. It is an Indiana-based company that produces a large variety of drugs, including the drugs that treat diabetes, psoriatic arthritis, bipolar disorder, migraine, depressive symptoms, and cancer. 

The company has an agreement with the European Commission to distribute the medicines for Covid-19 to the European Union (EU) and European Economic Area (EEA). This was a huge breakthrough in these markets where people are struggling to find the right medicine against the disease. 

The leading shareholder in the company is a Washington-based hedge fund firm Fisher Asset Management. This firm owns more than 6 million shares that have a value of $1.37 billion. 

Penny Stocks in Pharma Sector

It is well known that some companies have lower-valued stocks that you can buy at the moment. These companies are developing medicines for many diseases. However, the risk is also huge because all of the drugs have to pass rigorous tests and approvals before they reach the users. 

The best pharma penny stocks are there to offer you the best return on investment and these companies are here to stay. You should consider companies like Catalyst Pharmaceuticals, Cerecor, and Acasti Pharma when you want to invest your money in pharma penny stocks. 

No matter if you are investing in established companies or in those that are rising, you should be aware of the possible risk. At the same time, the lucrative outcomes can also be part of the success story. It is up to you to decide on where to invest your money and how to distribute it over the multiple sources of possible income. 

Christy Gren
Christy Gren is an Industry Specialist Reporter at Industry Leaders Magazine she enjoys writing about Unicorns, Silicon Valley, Startups, Business Leaders and Innovators. Her articles provide an insight about the Power Players in the field of Technology, Auto, Manufacturing, and F&B.

Recent Posts

Bay Area Businesses Brace for New COVID-19 Omicron Variant

Bay Area Businesses Brace for New COVID-19 Omicron Variant

San Francisco braces for the likely arrival of the new Covid-19 variant known as Omicron. The latest variant has a reproduction rate of two.
5 hours ago
Omicron Variant Pushes Markets into Panic Selling

Omicron Variant Pushes Markets into Panic Selling

Markets across the globe rush to safer havens as the resurgence of the Omicron variant spells fear of economic suffering due to potential lockdown orders.
6 hours ago
Loeb’s Third Point rakes in $300m from Rivian’s IPO

Loeb’s Third Point rakes in $300m from Rivian’s IPO

Dan Loeb’s hedge fund Third Point made a profit of about $300 million from its stake in electric car maker Rivian’s blockbuster US IPO earlier this month.
2 days ago
Best Electric Bikes for Any Budget & Terrain (2022)

Best Electric Bikes for Any Budget & Terrain (2022)

Industry Leaders has curated details and insights on the five best electric bikes that will be available by 2022.
3 days ago
3 Invaluable Leadership Lessons from Jeff Bezos

3 Invaluable Leadership Lessons from Jeff Bezos

Jeff Bezos is an American entrepreneur with so much experience in leadership and business. We can learn a lot from the New Mexico-born billionaire.
3 days ago
Payhawk raises $112 million in round 2

Payhawk raises $112 million in round 2

Payhawk, the expenses and spend management startup with a focus on European customers, has raised a $112 million Series B round at a $570 million valuation.
4 days ago